Quarter Comparison
Revenue
Operating Income
Net Margin
Income Statement
Balance Sheet
Earnings Release
EX-99.1 2 vnrx_ex991.htm PRESS RELEASE vnrx_ex991.htm EXHIBIT 99.1 VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update Conference call to discuss financial and operational results scheduled for Friday, August 14 at 8:30 a.m.
EX-99.1 2 vnrx_ex991.htm PRESS RELEASE vnrx_ex991.htm EXHIBIT 99.1 VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update Conference call to discuss financial and operational results scheduled for Friday, August 14 at 8:30 a.m. U.S. Eastern Time Henderson, Nevada, August 13, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, today announces financial results and a business update for the second quarter of 2026. Volition management will host a conference call tomorrow, August 14 at 8:30 a.m. U.S. Eastern Time/2:30 p.m. Central European Time to discuss these results. Conference call details can be found below. Cameron Reynolds , President and Group Chief Executive Officer, said: “We have made strong progress across all of our product pillars throughout 2026 to date. “We are currently in discussio...
Source
Exhibit EX-99.1
0001477932-26-004991
Filed August 13, 2026 at 8:32 PM UTC. The figures above are from the audited statements, not from this release.